Welcome to our dedicated page for Global Medical SEC filings (Ticker: GMRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Chiron Real Estate Inc., formerly Global Medical REIT Inc., files SEC reports documenting the public-company record of its net-lease medical REIT business and operating partnership structure. Its filings cover operating and financial results, earnings supplements, dividend and preferred-stock disclosures, shareholder voting matters, board composition and governance events.
Material-event filings also document capital-structure arrangements such as senior unsecured note facilities, master note and guaranty agreements, and related operating partnership obligations. The record includes the completed corporate name change from Global Medical REIT to Chiron Real Estate and associated issuer-status disclosures.
Global Medical REIT Inc. (GMRE) reported a third‑quarter 2025 net loss attributable to common stockholders of approximately $6.0 million, or $0.45 per diluted share, compared with net income of approximately $1.8 million, or $0.14 per diluted share, in the prior‑year period. For the nine months ended September 30, 2025, net loss attributable to common stockholders was approximately $4.7 million, or $0.35 per diluted share, versus a net loss of approximately $0.6 million, or $0.04 per diluted share, a year earlier.
Operating metrics were mixed. Same‑store cash NOI grew 2.7% year over year in Q3. Adjusted EBITDAre was $25.7 million for the quarter, with Net Debt/Annualized Adjusted EBITDAre at 6.9x. The portfolio was 95.2% occupied as of September 30, 2025, spanning approximately 5.2 million leasable square feet and generating $118.4 million annualized base rent. Weighted average lease term was 5.3 years. The rent mix was about 72% outpatient medical buildings, 25% inpatient rehabilitation facilities, hospitals, and LTACHs, and 3% other medical real estate.
Global Medical REIT Inc. (GMRE) reported a third‑quarter 2025 net loss attributable to common stockholders of approximately $6.0 million, or $0.45 per diluted share, compared with net income of approximately $1.8 million, or $0.14 per diluted share, in the prior‑year period. For the nine months ended September 30, 2025, net loss attributable to common stockholders was approximately $4.7 million, or $0.35 per diluted share, versus a net loss of approximately $0.6 million, or $0.04 per diluted share, a year earlier.
Operating metrics were mixed. Same‑store cash NOI grew 2.7% year over year in Q3. Adjusted EBITDAre was $25.7 million for the quarter, with Net Debt/Annualized Adjusted EBITDAre at 6.9x. The portfolio was 95.2% occupied as of September 30, 2025, spanning approximately 5.2 million leasable square feet and generating $118.4 million annualized base rent. Weighted average lease term was 5.3 years. The rent mix was about 72% outpatient medical buildings, 25% inpatient rehabilitation facilities, hospitals, and LTACHs, and 3% other medical real estate.
Global Medical REIT Inc. (GMRE) filed its Q3 2025 report, showing steady rent growth but a quarterly loss driven by an impairment. Rental revenue was $37,036 in the quarter and total revenue was $37,229. Expenses rose on depreciation and interest, and the Company recorded a $6,281 impairment, resulting in net loss attributable to common stockholders of $6,001, or $0.45 per share.
For the nine months, total revenue reached $109,816 with operating cash flow of $51,977. GMRE acquired a five‑property medical real estate portfolio and completed five dispositions across Kansas, Oregon, Florida, Tennessee, and Illinois. The Company executed a 1‑for‑5 reverse stock split effective September 19, 2025, and reported 13,407,358 common shares outstanding as of November 3, 2025.
Balance sheet highlights include total assets of $1,273,238 and Credit Facility borrowings of $711,700 gross (Revolver $211,700, Term Loans $500,000). Subsequent to quarter end, on October 8, 2025 GMRE amended and restated its Credit Facility, extending the Revolver to October 2029, splitting Term Loan A into tranches maturing in 2029, 2030, and 2031, and removing the 0.10% SOFR spread adjustment.
Global Medical REIT Inc. (GMRE) furnished its Third Quarter 2025 results materials. On November 4, 2025, the company announced its financial position as of September 30, 2025 and operating results for the three and nine months ended September 30, 2025. The earnings release (Exhibit 99.1) and earnings supplemental (Exhibit 99.2) were posted to its website and furnished with this report.
The materials are furnished, not filed, under the Exchange Act and are not subject to Section 18 liabilities, nor incorporated by reference into other filings.
Global Medical REIT Inc. amended its credit facilities to extend maturities and reprice a spread adjustment. The $400M revolver maturity is extended to October 2029 with two six-month extension options exercisable by the company to push the maturity to October 2030. The existing $350M term loan is split into three tranches: a $100M term loan maturing October 2029, a $100M term loan maturing October 2030, and a $150M term loan maturing April 2031. The amendment also removes a prior 0.10% (10 basis point) SOFR credit spread adjustment on all facility borrowings.
Global Medical REIT Inc. approved and implemented a one-for-five reverse stock split of its common stock. Effective as of 5:00 p.m. Eastern Time on September 19, 2025, every five shares of issued and outstanding common stock were converted into one share.
The reverse split temporarily changed the par value of common stock from $0.001 to $0.005 per share at the effective time, then immediately reverted it back to $0.001 per share. Authorized common shares were proportionately reduced from 500,000,000 to 100,000,000, while the 10,000,000 authorized preferred shares and their par value were unchanged.
The common stock will begin trading on a reverse split-adjusted basis on the NYSE on September 22, 2025, continuing under the symbol GMRE with a new CUSIP. Fractional share interests will be paid in cash based on the September 19, 2025 NYSE closing price, and all record holders are affected uniformly aside from minor changes from eliminating fractions. Equity plan share limits, outstanding awards, and related price-based performance metrics were adjusted proportionately.
Global Medical REIT Inc. approved and implemented a one-for-five reverse stock split of its common stock. Effective as of 5:00 p.m. Eastern Time on September 19, 2025, every five shares of issued and outstanding common stock were converted into one share.
The reverse split temporarily changed the par value of common stock from $0.001 to $0.005 per share at the effective time, then immediately reverted it back to $0.001 per share. Authorized common shares were proportionately reduced from 500,000,000 to 100,000,000, while the 10,000,000 authorized preferred shares and their par value were unchanged.
The common stock will begin trading on a reverse split-adjusted basis on the NYSE on September 22, 2025, continuing under the symbol GMRE with a new CUSIP. Fractional share interests will be paid in cash based on the September 19, 2025 NYSE closing price, and all record holders are affected uniformly aside from minor changes from eliminating fractions. Equity plan share limits, outstanding awards, and related price-based performance metrics were adjusted proportionately.
Global Medical REIT Inc. director Matthew Cypher purchased 1,350 shares of the company's common stock on 08/26/2025 at a price of $7.3781 per share. After the transaction he beneficially owns 1,350 shares, held directly. The Form 4 was signed by an attorney-in-fact, Jamie Barber, on the same date.
Jamie Allen Barber, who serves as General Counsel and Secretary and is identified as a director, reported the sale of 130,000 shares of Global Medical REIT Inc. (GMRE) on 08/15/2025. The Form 4 shows the shares were sold at a weighted average price of $6.6236 (individual trade prices ranged from $6.50 to $6.74). Following the reported transactions the filing indicates 0 shares beneficially owned by the reporting person. The form was signed on 08/18/2025 and was filed by one reporting person.
Global Medical REIT Inc. (GMRE) director and CEO Mark O. Decker Jr. reported purchases of common stock on 08/15/2025: 13,871 shares at $6.84 (direct), and 17,023 shares at $6.87 (indirect via spouse). After these transactions he beneficially owned 173,871 shares directly and 190,894 shares indirectly.
Global Medical REIT Inc. (GMRE) Form 144: This notice reports a proposed sale of 130,000 common shares, with an aggregate market value of $878,000.00. The shares were acquired on 08/07/2025 as a stock award from the issuer and paid as compensation. The filer lists Fidelity Brokerage Services LLC (245 Summer Street, Boston MA) as the broker and identifies an approximate sale date of 08/15/2025 on the NYSE. The issuer's reported number of shares outstanding is 66,878,728. The filing states there were no securities sold in the past three months by the person for whose account the securities will be sold. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Jamie Barber, who serves as General Counsel and Secretary and is a director of Global Medical REIT Inc. (GMRE), converted 130,000 long-term incentive plan units (LTIP Units) in the operating partnership into OP Units and had those OP Units redeemed for an equal number of the issuer's common shares. As a result, Barber directly beneficially owns 130,000 shares of GMRE common stock following the transaction. The filing states LTIP Units were issued under the 2016 Equity Incentive Plan and have no expiration date, and OP Units may be redeemed for cash or, at the issuer's election, for one-for-one shares of common stock.